HomeVadadustatVadadustat + Sulfasalazine

Does Vadadustat Interact with Sulfasalazine?

Vadadustat and Sulfasalazine have a moderate drug interaction according to U.S. FDA drug labeling data. Vadadustat may increase sulfasalazine exposure as a BCRP substrate. Monitor for adverse effects and reduce dosage if needed. The mechanism involves bcrp substrate inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Vadadustat Class
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor
Sulfasalazine Class
Aminosalicylate
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Vadadustat and Sulfasalazine occurs because bcrp substrate inhibition. Clinically, this means vadadustat may increase sulfasalazine exposure as a bcrp substrate. monitor for adverse effects and reduce dosage if needed. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Vadadustat and your doctor is considering prescribing Sulfasalazine (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Vadadustat(Vafseo)+💊 Sulfasalazine(Sulfasalazine)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor
Drug B class
Aminosalicylate
Source
NLP:vadadustat

What this means in plain English

Vadadustat may increase sulfasalazine exposure as a BCRP substrate. Monitor for adverse effects and reduce dosage if needed.

What the FDA label says

"BCRP substrate inhibition"

📖 Source: NLP:vadadustat

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Vadadustat and Sulfasalazine against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.